Jeffrey Weber, MD, PhD, discusses the unmet needs professionals take into consideration when deciding treatment options for patients with melanoma.
Jeffrey Weber, MD, PhD
Advertisement
Articles by Jeffrey Weber, MD, PhD
Medicial oncologist and melanoma expert Dr. Jeffrey Weber discusses the role of adjuvant immunotherapy in the setting of stage III melanoma.
Advertisement
Latest Updated Articles
Jeffrey Weber, MD, PhD, Describes Unmet Needs for Patients with MelanomaNovember 14th 2020
Adjuvant Immunotherapy in Advanced MelanomaMarch 22nd 2018
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
3
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
4
Selinexor Combo Improves Spleen Volume Reduction in Myelofibrosis
5